Loading clinical trials...
Loading clinical trials...
Pilot Study of Personalized Neoantigen Peptide Vaccines and Leukine for the Treatment of Neoplasms
Conditions
Interventions
Neoantigen Peptides
Locations
1
Mexico
Instituto de Medicina Regenerativa
Tijuana, Estado de Baja California, Mexico
Start Date
May 12, 2022
Primary Completion Date
November 25, 2025
Completion Date
June 20, 2026
Last Updated
March 6, 2024
NCT03206060
NCT07541924
NCT07542041
NCT06608446
NCT00033137
NCT04389632
Lead Sponsor
Instituto de Medicina Regenerativa
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions